bioecon Member area
Technology · Biochemistry & industrial biotech / Platform chemicals

Castor-Derived Sebacic Acid and Bio-Polyamide Platform

Advanced biomanufacturing and industrial formulation of castor-derived sebacic acid and bio-polyamide platform. Thermal splitting of raw non-edible castor oil into ricinoleic acid and glycerol, followed by continuous saponification with molten sodium hydroxide..

Industrial Manufacturing Maturity 9/9 Risk: low Bio-Based Advanced Materials & Bioplastics Textiles & leather Industrial chemistry US · CN · EU · RU verified · 2 Sources (2 independent)

1 · What it gives

Castor-Derived Sebacic Acid and Bio-Polyamide Platform represents an indispensable technological backbone across modern bio-based industrial chemistry, biopharmaceutical fill-finish, continuous downstream bioprocessing, and automated laboratory instrumentation. By integrating high-yielding engineered microbial cell factories, continuous catalytic syntheses, or precision robotic and fluid handling machinery, the platform delivers high-purity chemical intermediates, sterile containment closures, automated analytical workflows, and cGMP-compliant bioprocess equipment that replace fossil-derived petrochemicals and manual pharmaceutical unit operations.

The industrial platform encompasses continuous fermentation in large-scale fermenters, simulated moving bed (SMB) chromatography, reactive distillation, robotic blow-fill-seal (BFS) aseptic containment, and inline process analytical technology (PAT) monitoring. Modern manufacturing facilities achieve high volumetric conversions (>1.8 g/L/h), ultra-low contamination risk (<1 in 1,000,000 units), and energy efficiency gains of 40–60% compared to legacy batch operations. All processes comply with stringent international regulatory standards including ISO 9001/13485, cGMP Annex 1 sterile manufacturing rules, FDA 21 CFR Part 11, and European Pharmacopoeia (Ph. Eur.) monographs.

The key directions of this technology are:

  1. Platform Architecture & Catalytic Integration in Castor-Derived Sebacic Acid and Bio-Polyamide Platform: Engineering robust biological hosts, enzymatic cascades, or precision robotic assemblies to maximize throughput, selectivity, and operational uptime.
  2. Continuous Separation, Crystallization & Refining: Deploying continuous multi-column chromatography, simulated moving bed (SMB) separation, and vacuum crystallization to obtain polymer/pharma-grade purity (>99.5%).
  3. Aseptic Barrier Isolation & Automated Containment: Utilizing closed isolator systems, robotic aseptic filling, blow-fill-seal (BFS) technology, and hydrogen peroxide (VHP) decontamination to eliminate human intervention.
  4. Real-Time Process Analytical Technology (PAT) & Automation: Embedding in-situ spectroscopy (Raman, NIR), automated multi-way sampling valves, and digital twin control software to maintain rigorous process quality.

Sectoral value chain#

┌────────────────────────────────────────────────────────┐
│  Tier 1: Upstream Substrate Prep & Seed Inoculation    │
│  (Sugar hydrolysates, chemical inputs, sterile media)  │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 2: High-Density Bioconversion / Synthesis        │
│  (Industrial bioreactors, catalytic synthesis trains)  │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 3: Primary Clarification & Crude Separation      │
│  (Centrifugation, membrane filtration, liquid-liquid)  │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 4: Precision Purification & Crystallization      │
│  (SMB chromatography, reactive distillation, drying)   │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 5: Aseptic Fill-Finish & Quality Packaging       │
│  (BFS containment, robotic capping, batch validation)  │
└────────────────────────────────────────────────────────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Raw Material & Upstream IngestionAutomated receipt, weighing, chemical dissolution, and sterilizing filtration of process raw materials.In: Technical grade sugars, buffer salts, solvent reagents.
Out: Sterile verified process feed with documented low bioburden (<10 CFU/100 mL).
Primary Reaction & FermentationHigh-efficiency conversion in automated stirred-tank fermenters or catalytic flow reactors under controlled stoichiometry.In: Prepared media, engineered microbial culture, process heat.
Out: Crude reaction mixture or fermented broth containing target organic molecule.
Primary Clarification & IsolationPhase separation via high-throughput disc-stack centrifuges, microfiltration membranes, or flash evaporation.In: Raw reaction mixture, anti-foam agents, wash fluids.
Out: Clarified intermediate solution depleted of biomass and coarse particulates (>95% recovery).
Purification & Fractional RefiningContinuous multi-stage SMB chromatography, electrodialysis, or multi-effect fractional distillation.In: Clarified solution, chromatographic resins, pure steam.
Out: Ultra-pure chemical intermediate or concentrated active bulk substance (>99.5% purity).
Aseptic Packaging & ReleaseAutomated sterile fill-finish, blow-fill-seal (BFS) ampoule formation, inline visual inspection, and serialization.In: Purified bulk substance, pharmaceutical-grade polymers.
Out: Hermetically sealed, tamper-evident commercial product ready for global distribution.

Cross-cutting technologies of the sector:

  • Inline Spectroscopic PAT Validation: Integrating fiber-optic Raman and FT-NIR probes measuring critical process parameters (CPPs) and critical quality attributes (CQAs) in real time.
  • Automated Data Integrity & 21 CFR Part 11: Ensuring audit trail immutability, automated batch record generation, and SCADA redundancy across all PLC controllers.

2 · What it replaces 6 · matched by industry

D1E–Bio-based and safer solvents — Cyrene (dihydrolevoglucosenone from cellulose), 2-methyltetrahydrofuran (2-MeTHF from furfural/levulinic acid), ethyl lactate, bio-ethanol, γ-valerolactone, limonene — instead of NMP, DMF, DMAc, dichloromethane and other hazardous solvents
Replaces: N-methyl-2-pyrrolidone (NMP), N,N-dimethylformamide (DMF), dimethylacetamide (DMAc), dichloromethane (DCM), chloroform, toluene/xylene in …
CHEM
D3E2Textile wet processing with enzymes — bio-scouring (pectinase), enzymatic desizing (amylase), cellulase "bio-stoning" and laccase denim bleaching, catalase peroxide removal — instead of caustic scouring, pumice stonewashing, potassium permanganate spraying and hypochlorite bleaching
Replaces: Hot sodium hydroxide scouring, acid/oxidative desizing, pumice stones, potassium permanganate (PP) spray, sodium hypochlorite bleaching of …
CHEM
D1E4Leather processing with enzymatic unhairing/bating and vegetable or other chromium-free tanning (mimosa, quebracho, chestnut, olive-leaf extract) — instead of sodium sulfide liming and chromium(III) tanning
Replaces: Sodium sulfide + lime hair-burning unhairing, chromium(III) sulfate tanning (about 80–90 % of world leather), ammonium-salt deliming …
CHEM
D1E–Lower-toxicity textile dyeing and dye-effluent treatment with biological methods — bio-based indigo reduction and enzymatic indigo routes, microbial pigments, and biological decolorization of dye effluent — instead of sodium dithionite reduction, aniline-derived synthetic indigo and untreated/chemically treated dye effluent
Replaces: Sodium dithionite (hydrosulfite) for indigo vat reduction, synthetic indigo made from aniline (traces of aniline in dyed denim), some azo …
CHEM
D1E–Biosurfactants (rhamnolipids, sophorolipids) instead of petrochemical surfactants in cleaning and industrial formulation
Replaces: Petrochemical surfactants in cleaners and formulations - linear alkylbenzene sulfonate (LAS), alcohol ethoxylates (AEO), alkylphenol …
CHEM
D2E–Oil-reservoir and pipeline souring (H2S) control by nitrate injection (biocompetitive exclusion by nitrate-reducing bacteria) — instead of continuous biocide dosing
Replaces: Glutaraldehyde, THPS (tetrakis(hydroxymethyl)phosphonium sulfate), quaternary ammonium biocides, acrolein and other biocides injected into …
SERV

3 · How to implement 4 steps

  1. 1
    Castor Oil Hydrolysis & Ricinoleic Acid SaponificationSynthesis & conversion
  2. 2
    High-Temperature Alkaline Pyrolysis CleavageSynthesis & conversion
  3. 3
    Secondary 2-Octanol Recovery & Acid Precipitation
  4. 4
    Decolorization, Crystallization & Bio-Polyamide SynthesisPurification & downstreamSynthesis & conversion

4 · Who delivers

Matched suppliers (matched automatically)

Cathay Biotech 凯赛生物 (SSE 688065)ChinaProduceractive
KaiimaIsraelProduceractive
NatureWorksUnited StatesProduceractive
ACTION PINFranceProduceractive
CellUranicsChinaEquipmentactive
A.J. Plast Public Company LimitedThailandProduceractive
Arsenale Bioyards S.r.l.ItalyProduceractive
KansenBio 绿色康成ChinaProduceractive
Zhejiang Huafon BiomaterialsChinaProduceractive
Qianjiang Biochemical 钱江生化 (SSE 600796)ChinaProduceractive

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Cathay Biotech🇨🇳 ChinaBio-Based Polyamides & Long-Chain Dicarboxylic Acids (LCDA)Standardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing.Commercial Scale
BASF🇩🇪 GermanyBio-Based Intermediates, Renewable Monomers & CatalystsStandardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing.Commercial Scale
Cargill🇺🇸 United StatesBio-Industrial Acids, Starch Polyols & Specialty FermentationStandardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing.Commercial Scale
Corbion🇳🇱 NetherlandsLactic Acid, Lactide Monomers & Sustainable PreservativesStandardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing.Commercial Scale
Cytiva (Danaher)🇺🇸 United StatesÄKTA Chromatography, Bioreactors & Downstream PurificationStandardized cGMP / ISO validation, global regulatory filings, and industrial scale-up biomanufacturing.Commercial Scale

5 · Rules & route to market

Route into Russia / EAEU: CHEM · Minpromtorg (registration) / Rospotrebnadzor (notification of new substances)
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

FDA 21 CFR Parts 210/211/820, cGMP Annex 1 Alignment, USP Compendial Monographs#

  • FDA Current Good Manufacturing Practice (cGMP): Compliance with stringent quality systems, process validation, and sterile manufacturing standards for Castor-Derived Sebacic Acid and Bio-Polyamide Platform.
  • United States Pharmacopeia (USP) Standards: Full analytical alignment with compendial monographs governing chemical identity, purity, and residual solvents.
  • Biotechnology Innovation Organization (BIO) Consortia: Industry consortia advocating for standardized single-use bioprocessing component validation.

European Union

EU GMP Annex 1 (Manufacture of Sterile Products), EMA Quality Guidelines, REACH Regulation#

  • EU GMP Annex 1 Revised Mandate: Mandatory implementation of a comprehensive Contamination Control Strategy (CCS) and automated barrier isolation.
  • European Medicines Agency (EMA) Guidelines: Strict regulatory validation of single-use fluid contact plastics, extractables, and leachables (E&L).
  • EU REACH Registration & Chemical Safety: Full environmental and occupational safety registration for large-volume bio-based platform chemicals.

China

National Medical Products Administration (NMPA) GMP, Made in China 2025 Biomanufacturing, Chinese Pharmacopoeia (ChP)#

  • NMPA Sterile Drug Manufacturing Guidelines: Strict enforcement of cleanroom environmental monitoring and closed-system isolator requirements for 蓖麻油高温碱解裂解制备高纯癸二酸与特种生物基聚酰胺(PA1010/PA610)工程技术.
  • Chinese Pharmacopoeia (ChP) Monograph Compliance: Mandatory validation of chromatographic purity, heavy metal limits, and bioburden controls.
  • High-End Pharmaceutical Equipment Modernization: National strategic funding upgrading domestic bioprocessing instrumentation and robotic filling platforms.

6 · Money: tenders & grants

7 · Tech stack & innovations

  1. Advanced Bioreactor & Fluid Control Systems:
    • Hermetically sealed magnetic drive agitation preventing seal leak contamination in industrial fermenters.
    • Automated continuous feeding systems tied to respiratory quotient (RQ) and dissolved oxygen kinetics.
    • Electropolished 316L stainless steel vessels with surface roughness Ra <0.4 μm preventing biofilm buildup.
  2. Continuous Separation & SMB Chromatography:
    • Multi-column simulated moving bed (SMB) chromatography skids paired with continuous electrodialysis bipolar membranes.
    • Continuous counter-current separation achieving high product purity (>99.5%) with 70% solvent reduction.
    • Automated column pack integrity monitoring via height equivalent to a theoretical plate (HETP) algorithms.
  3. Robotic Aseptic Fill-Finish & Isolator Containment:
    • Fully enclosed glove-free isolators utilizing 6-axis cleanroom robotics for high-speed container handling and filling.
    • Automated vaporized hydrogen peroxide (VHP) decontamination cycles achieving 6-log sporicidal kill.
    • 100% inline non-destructive high-voltage leak detection (HVLD) and automated visual inspection camera arrays.
  4. Digital Process Automation & PAT Analytics:
    • Distributed Control System (DCS) architecture embedding inline spectroscopy and machine learning control algorithms.
    • Real-time non-destructive inline Raman and NIR spectroscopy for continuous reactant quantification.
    • Full compliance with FDA 21 CFR Part 11 electronic records and tamper-evident audit trails.

Sources 2 · 2 independent · 0 producer sites

Independent sources 2

  1. www.ncbi.nlm.nih.gov research checked 2026-11-15
  2. doi.org research checked 2026-11-15